Gujarat Themis Biosyn Ltd banner

Gujarat Themis Biosyn Ltd
BSE:506879

Watchlist Manager
Gujarat Themis Biosyn Ltd Logo
Gujarat Themis Biosyn Ltd
BSE:506879
Watchlist
Price: 319.4 INR -2.83% Market Closed
Market Cap: ₹34.8B

Relative Value

The Relative Value of one GUJTHEM stock under the Base Case scenario is hidden INR. Compared to the current market price of 319.4 INR, Gujarat Themis Biosyn Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GUJTHEM Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

GUJTHEM Competitors Multiples
Gujarat Themis Biosyn Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Gujarat Themis Biosyn Ltd
BSE:506879
34.8B INR 22.4 72.1 50.7 57.1
US
Eli Lilly and Co
NYSE:LLY
964.4B USD 14.8 46.8 31.5 33.6
US
Johnson & Johnson
NYSE:JNJ
572.6B USD 6.1 21.3 14.9 18.2
CH
Roche Holding AG
SIX:ROG
284.3B CHF 4.6 30 12.7 14.8
US
Merck & Co Inc
NYSE:MRK
297.7B USD 4.6 16.3 10.2 11.9
CH
Novartis AG
SIX:NOVN
228.8B CHF 5.2 21.1 13 16.8
UK
AstraZeneca PLC
LSE:AZN
217.7B GBP 5.2 32 15.3 22.3
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 9.4 11
US
Pfizer Inc
NYSE:PFE
151.1B USD 2.4 19.4 7.3 9.7
US
Bristol-Myers Squibb Co
NYSE:BMY
120.9B USD 2.5 20 7.1 9.3
P/E Multiple
Earnings Growth PEG
IN
Gujarat Themis Biosyn Ltd
BSE:506879
Average P/E: 29.2
72.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
46.8
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
21.3
6%
3.6
CH
Roche Holding AG
SIX:ROG
30
29%
1
US
Merck & Co Inc
NYSE:MRK
16.3
14%
1.2
CH
Novartis AG
SIX:NOVN
21.1
15%
1.4
UK
AstraZeneca PLC
LSE:AZN
32
38%
0.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
7%
1.8
US
Pfizer Inc
NYSE:PFE
19.4
26%
0.7
US
Bristol-Myers Squibb Co
NYSE:BMY
20
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Gujarat Themis Biosyn Ltd
BSE:506879
Average EV/EBITDA: 45.9
50.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
31.5
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.4
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
US
Merck & Co Inc
NYSE:MRK
10.2
7%
1.5
CH
Novartis AG
SIX:NOVN
13
9%
1.4
UK
AstraZeneca PLC
LSE:AZN
15.3
10%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.4
7%
1.3
US
Pfizer Inc
NYSE:PFE
7.3
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.1
-9%
N/A